{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:43:08Z","timestamp":1789159388059,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1193826"],"award-info":[{"award-number":["1193826"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2007919"],"award-info":[{"award-number":["2007919"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128127","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:18:08Z","timestamp":1766085488000},"page":"128127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Estimating risk of long COVID using a Bayesian network-based decision support tool"],"prefix":"10.1016","volume":"72","author":[{"given":"Jane E.","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.B.","family":"Litt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty R.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128127_bb0005","unstructured":"World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0010","unstructured":"World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(covid-19)-post-covid-19-condition. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14357","article-title":"Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review","volume":"75","author":"Cabrera Martimbianco","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.vaccine.2025.128127_bb0020","article-title":"Covid-19: middle aged women face greater risk of debilitating long term symptoms","volume":"372","author":"Torjesen","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128127_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003773","article-title":"Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19","volume":"18","author":"Taquet","year":"2021","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128127_bb0030","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/dom.14454","article-title":"Association of obesity with postacute sequelae of COVID-19","volume":"23","author":"Aminian","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128127_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102235","article-title":"Post COVID-19 syndrome (\u201clong COVID\u201d) and diabetes: challenges in diagnosis and management","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"10.1016\/j.vaccine.2025.128127_bb0040","doi-asserted-by":"crossref","unstructured":"Yang J, Zheng Y, Gou X et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis, 94, 91\u201395. doi:https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017.","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"10.1016\/j.vaccine.2025.128127_bb0045","unstructured":"National Center for Health Statistics. U.S. Census Bureau, Household Pulse Survey, 2022\u20132024. Long COVID. https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0050","doi-asserted-by":"crossref","unstructured":"Davis HE, Assaf GS, McCorkell L et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact eClinicalMedicine, Volume 38, 101019.","DOI":"10.1016\/j.eclinm.2021.101019"},{"key":"10.1016\/j.vaccine.2025.128127_bb0055","doi-asserted-by":"crossref","unstructured":"Seeley, MC., Gallagher, C., Ong, E. et al. Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population. Clin Auton Res 33, 469\u2013477 (2023). doi:https:\/\/doi.org\/10.1007\/s10286-023-00955-9.","DOI":"10.1007\/s10286-023-00955-9"},{"key":"10.1016\/j.vaccine.2025.128127_bb0060","unstructured":"Australian Partnership for Preparedness Research on infectious disease emergencies. Doherty Modelling Report Revised 10th August 2021. https:\/\/www.apprise.org.au\/publication\/doherty-modelling-report-revised-10th-august-2021\/. [Accessed 30 Oct, 2024]."},{"key":"10.1016\/j.vaccine.2025.128127_bb0065","unstructured":"Long COVID SOS. At the Covid Inquiry Cabinet Secretary Simon Case struggles under questioning from the Long Covid Groups' KC. https:\/\/www.longcovidsos.org\/post\/at-the-covid-inquiry-cabinet-secretary-simon-case-struggles-under-questioning-from-the-long-covid-gr. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0070","unstructured":"World Health Organization. COVID-19 policy briefs. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-policy-briefs. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0075","article-title":"Covid-19: show us evidence for lifting restrictions, doctors tell Johnson","volume":"376","author":"Waters","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.128127_bb0080","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128127_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25657","article-title":"Health care utilization in the 6 months following SARS-CoV-2 infection","volume":"5","author":"Tartof","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.128127_bb0090","unstructured":"Gonzalez, A. E. & Suzuki, E. The impacts of long COVID across OECD countries. OECD Health Working Papers 167 (OECD Publishing, 2024)."},{"key":"10.1016\/j.vaccine.2025.128127_bb0095","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.128127_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074572","article-title":"Molnupiravir and risk of post-acute sequelae of covid-19: cohort study","volume":"381","author":"Xie","year":"2023","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128127_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","article-title":"Association of Treatment with Nirmatrelvir and the risk of post\u2013COVID-19 condition","volume":"183","author":"Xie","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128127_bb0110","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1473-3099(23)00299-2","article-title":"Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial","volume":"23","author":"Bramante","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128127_bb0115","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.128127_bb0120","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1038\/s41467-021-26513-3","article-title":"Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status","volume":"12","author":"Xie","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128127_bb0125","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1016\/j.vaccine.2021.10.079","article-title":"Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework","volume":"39","author":"Lau","year":"2021","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2025.128127_bb0130","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.vaccine.2022.04.004","article-title":"Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine","volume":"40","author":"Mayfield","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128127_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41541-022-00517-6","article-title":"A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia","volume":"7","author":"Sinclair","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.128127_bb0140","unstructured":"Immunisation Coalition. CoRiCal: COVID-19 Risk Calculator. https:\/\/corical.immunisationcoalition.org.au\/. Accessed 30 Oct, 2024."},{"issue":"24","key":"10.1016\/j.vaccine.2025.128127_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126296","article-title":"Using health literacy principles to improve understanding of evolving evidence in health emergencies: optimisation and evaluation of a COVID-19 vaccination risk-benefit calculator","volume":"42","author":"Bonner","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128127_bb0150","doi-asserted-by":"crossref","unstructured":"Ziyad Al-Aly, Benjamin Bowe, Yan Xie et al. Outcomes of SARS-CoV-2 Reinfection, 17 June 2022, PREPRINT (Version 1) available at Research Square [doi:10.21203\/rs.3.rs-1749502\/v1].","DOI":"10.21203\/rs.3.rs-1749502\/v1"},{"key":"10.1016\/j.vaccine.2025.128127_bb0155","series-title":"Probabilistic reasoning in intelligent systems: Networks of plausible inference","author":"Pearl","year":"1988"},{"key":"10.1016\/j.vaccine.2025.128127_bb0160","series-title":"Risk assessment and decision analysis with Bayesian networks","author":"Fenton","year":"2019"},{"key":"10.1016\/j.vaccine.2025.128127_bb0165","unstructured":"Australian Bureau of Statistics. Table 8. Estimated resident population, by age and sex\u2013at 30 June 2021. https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/jun-2021\/31010do002_202106.xlsx Table 8. Estimated resident population, by age and sex\u2013at 30 June 2021."},{"key":"10.1016\/j.vaccine.2025.128127_bb0170","unstructured":"Australian Bureau of Statistics. Table 18.3. Number of selected chronic diseases(a) by population characteristics, Proportion of persons. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/4364.0.55.0012014-15. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0175","unstructured":"Australian Government Department of Health and Aged Care. COVID-19 vaccination \u2013 vaccination data \u2013 26 May 2023. https:\/\/www.health.gov.au\/resources\/publications\/covid-19-vaccination-vaccination-data-26-may-2023?language=en. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0180","unstructured":"NSW Health. COVID-19 WEEKLY SURVEILLANCE IN NSW Epidemiological week 5, ending 5 February 2022. https:\/\/www.health.nsw.gov.au\/Infectious\/covid-19\/Documents\/covid-19-surveillance-report-20220223.pdf. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0185","unstructured":"UK Health security agency. COVID-19 vaccine surveillance report Week 5 3 February 2022. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1052353\/Vaccine_surveillance_report_-_week_5.pdf. [Accessed 30 Oct, 2024]."},{"key":"10.1016\/j.vaccine.2025.128127_bb0190","unstructured":"UK Health security agency. COVID-19 vaccine surveillance report Week 14 6 April 2023. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1149407\/vaccine-surveillance-report-2023-week-14.pdf. [Accessed 30 Oct, 2024]."},{"key":"10.1016\/j.vaccine.2025.128127_bb0195","unstructured":"UK Health security agency. COVID-19 vaccine surveillance report Week 24 16 June 2022. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1083443\/Vaccine-surveillance-report-week-24.pdf. [Accessed 30 Oct, 2024]."},{"key":"10.1016\/j.vaccine.2025.128127_bb0200","unstructured":"GOV.UK. UKHSA data dashboard Showing public health data across England. https:\/\/coronavirus.data.gov.uk\/details\/cases. Accessed 30 Oct, 2024."},{"key":"10.1016\/j.vaccine.2025.128127_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecolmodel.2017.05.011","article-title":"Common quandaries and their practical solutions in Bayesian network modeling","volume":"358","author":"Marcot","year":"2017","journal-title":"Ecol Model"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128127_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eswa.2012.07.026","article-title":"A proposed validation framework for expert elicited Bayesian networks","volume":"40","author":"Pitchforth","year":"2013","journal-title":"Expert Syst Appl"},{"key":"10.1016\/j.vaccine.2025.128127_bb0215","unstructured":"Per B. Sederberg. SMILE Revision ab9e5e59 2016. https:\/\/smile-docs.readthedocs.io\/en\/latest\/. [Accessed 30 Oct, 2024]."},{"issue":"6","key":"10.1016\/j.vaccine.2025.128127_bb0220","article-title":"Extending the range of COVID-19 risk factors in a Bayesian network model for personalised risk assessment","volume":"4","author":"Prodhan","year":"2020","journal-title":"Epidemol Int J"},{"key":"10.1016\/j.vaccine.2025.128127_bb0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43856-024-00506-x","article-title":"Complex patterns of multimorbidity associated with severe COVID-19 and long COVID","volume":"4","author":"Pietzner","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.vaccine.2025.128127_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104777","article-title":"Predictive models of long COVID","volume":"96","author":"Antony","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.vaccine.2025.128127_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jep.13900","article-title":"How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines","volume":"30","author":"Doshi","year":"2024","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.vaccine.2025.128127_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074404","article-title":"The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies","volume":"381","author":"Monge","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.128127_bb0245","unstructured":"Immunisation Coalition. CoRiCal: COVID-19 Risk Calculator \u2013 Video Overview. https:\/\/corical.immunisationcoalition.org.au\/videos. Accessed 30 Oct, 2024."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:39:14Z","timestamp":1768941554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0264410X25014252"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128127","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating risk of long COVID using a Bayesian network-based decision support tool","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128127"}}